![Leif Schimmel Hamø](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Leif Schimmel Hamø
Nessuna posizione attualmente
Profilo
Leif Schimmel Hamø worked as a Chief Executive Officer at AcceptFinans ApS, Chief Financial Officer & Executive Director at NextGen Group Plc, and Chief Financial Officer at Topotarget A from 2002 to 2009.
Precedenti posizioni note di Leif Schimmel Hamø
Società | Posizione | Fine |
---|---|---|
TOPOTARGET A/S | Direttore Finanziario/CFO | - |
AcceptFinans ApS
![]() AcceptFinans ApS Finance/Rental/LeasingFinance Part of GE Aerospace, AcceptFinans ApS is a Danish company that provides consumer lending services. The company is located in Denmark. AcceptFinans was acquired by General Electric Capital Corp. from Gjensidige Nor Sparebanken ASA on August 03, 2001. | Presidente | - |
NextGen Group Plc
![]() NextGen Group Plc Miscellaneous Commercial ServicesCommercial Services NextGen Group Plc provides protein biomarker testing services for pharmaceutical and biotech companies. Its services include biomarker discover, assay development and testing laboratory. The company's biomarker assay used to test pre-clinical and clinical samples for drug efficacy and safety, and for the development of personalized treatment for patients. Its biomarker services include protein identification, characterization, quantitation and proteome mapping. The company was founded on September 7, 2005 and is headquartered in London, the United Kingdom. | Direttore Finanziario/CFO | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 3 |
---|---|
NextGen Group Plc
![]() NextGen Group Plc Miscellaneous Commercial ServicesCommercial Services NextGen Group Plc provides protein biomarker testing services for pharmaceutical and biotech companies. Its services include biomarker discover, assay development and testing laboratory. The company's biomarker assay used to test pre-clinical and clinical samples for drug efficacy and safety, and for the development of personalized treatment for patients. Its biomarker services include protein identification, characterization, quantitation and proteome mapping. The company was founded on September 7, 2005 and is headquartered in London, the United Kingdom. | Commercial Services |
Topotarget A/S
![]() Topotarget A/S Pharmaceuticals: MajorHealth Technology Topotarget A/S is a biotechnology company that is engaged in the development and commercialization of novel drugs for the treatment of cancer. Its product belinostat is a novel histone deacetylase inhibitor which is used for cancer patients. The company was founded by Peter Buhl Jensen and Maxwell Sehested in 2000 and is headquartered in Copenhagen, Denmark. | Health Technology |
AcceptFinans ApS
![]() AcceptFinans ApS Finance/Rental/LeasingFinance Part of GE Aerospace, AcceptFinans ApS is a Danish company that provides consumer lending services. The company is located in Denmark. AcceptFinans was acquired by General Electric Capital Corp. from Gjensidige Nor Sparebanken ASA on August 03, 2001. | Finance |
- Borsa valori
- Insiders
- Leif Schimmel Hamø